All stock lists
Perspective Therapeutics, Inc. (New York Stock Exchange Arca:CATX)
US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
1.25-0.35 (-22.05%)
Insider Score
––Not scored
CATX Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
CATX analyst forecast
CATX analyst consensus
No analyst ratings in the last 3 months.
CATX 12-month price target
$4.00+220.0% upsideaverage of 1 firm
$4.00High
$4.00Low
Best analysts covering CATX
No firm covering CATX has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
CATX analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| RBC Capital | — | $4.00 | +148.4% | — | 2026-10-26 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.